The interaction of PD-L1 with its counter-receptor programmed cell death-1 (PD-1) expressed by activated T lymphocytes, inhibits T-cell activation and proliferation, thus contributing to cancer immune evasion5. The gene discussed is CD274; the disease is cancer.